Lectin-like oxidized low-density lipoprotein receptor-1: protein, ligands, expression and pathophysiological significance
- PMID: 17376315
Lectin-like oxidized low-density lipoprotein receptor-1: protein, ligands, expression and pathophysiological significance
Abstract
Objective: To review the recent research progress in lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) including its protein, ligands, expression and pathophysiological significance. Data sources Information included in this article was identified by searching of PUBMED (1997 - 2006) online resources using the key term LOX-1.
Study selection: Mainly original milestone articles and critical reviews written by major pioneer investigators of the field were selected.
Results: The key issues related to the LOX-1 protein as well as ligands for LOX-1. Factors regulating the expression of LOX-1 were summarized. The pathophysiological functions of LOX-1 in several diseases were discussed.
Conclusions: Identification of LOX-1 and a definition of its biological role in pathophysiologic states provide deeper insight into the pathogenesis of some cardiovascular diseases especially in atherosclerosis and provide a potential selective therapeutic approach. LOX-1 is unlocking and drugs targeting LOX-1 might be a promising direction to explore.
Similar articles
-
Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?Cardiovasc Drug Rev. 2007 Summer;25(2):146-61. doi: 10.1111/j.1527-3466.2007.00009.x. Cardiovasc Drug Rev. 2007. PMID: 17614937 Review.
-
Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay.Cell Biochem Funct. 2008 Oct;26(7):760-70. doi: 10.1002/cbf.1502. Cell Biochem Funct. 2008. PMID: 18636435
-
Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor.Trends Cardiovasc Med. 2006 Feb;16(2):60-4. doi: 10.1016/j.tcm.2005.12.001. Trends Cardiovasc Med. 2006. PMID: 16473764 Review.
-
Lectin-like oxidized low-density lipoprotein receptor (LOX-1) functions as an oligomer and oligomerization is dependent on receptor density.Exp Cell Res. 2007 Apr 1;313(6):1203-14. doi: 10.1016/j.yexcr.2007.01.007. Epub 2007 Jan 17. Exp Cell Res. 2007. PMID: 17306253
-
Chimeric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).J Biochem. 2007 Jun;141(6):855-66. doi: 10.1093/jb/mvm093. Epub 2007 Apr 6. J Biochem. 2007. PMID: 17416594
Cited by
-
Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.Medicine (Baltimore). 2018 Apr;97(17):e0366. doi: 10.1097/MD.0000000000010366. Medicine (Baltimore). 2018. PMID: 29702981 Free PMC article.
-
The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors.FEMS Microbiol Lett. 2009 Jan;290(2):121-8. doi: 10.1111/j.1574-6968.2008.01418.x. Epub 2008 Jan 11. FEMS Microbiol Lett. 2009. PMID: 19025564 Free PMC article. Review.
-
LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions.Mol Cell Biochem. 2024 Sep;479(9):2245-2254. doi: 10.1007/s11010-023-04859-0. Epub 2023 Oct 3. Mol Cell Biochem. 2024. PMID: 37789136 Review.
-
Differential pro-inflammatory responses of TNF-α receptors (TNFR1 and TNFR2) on LOX-1 signalling.Mol Biol Rep. 2015 Jun;42(6):1039-47. doi: 10.1007/s11033-014-3841-y. Epub 2014 Nov 23. Mol Biol Rep. 2015. PMID: 25416967
-
LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients.Cell Oncol (Dordr). 2018 Feb;41(1):73-84. doi: 10.1007/s13402-017-0360-6. Epub 2017 Nov 22. Cell Oncol (Dordr). 2018. PMID: 29168159
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources